In early‐stage AD models, α7‐nAChRs exert neuroprotective effects by maintaining the septohippocampal cholinergic phenotype, preserving hippocampal integrity, and reducing Aβ accumulation and aggregation [7]. Here, CHRNA7 is linked to Alzheimer disease.